Therapeutic effects in ocular lesions obtained by systematic and topical administration of an activator of the oxygen metabolism.
D000183:Actihaemyl / Q000008:administration & dosage / Q000627:therapeutic use*; D000287:Administration, Topical; D000818:Animals; D001565:Benzoates / Q000633:toxicity; D019817:Benzoic Acid; D002924:Ciliary Body / Q000187:drug effects; D003261:Contact Lenses / Q000009:adverse effects; D003315:Cornea / Q000187:drug effects / Q000378:metabolism; D065306:Corneal Injuries; D004353:Drug Evaluation, Preclinical; D005128:Eye Diseases / Q000188:drug therapy*; D005131:Eye Injuries / Q000517:prevention & control; D005260:Female; D006168:Guinea Pigs; D007452:Iodates / Q000633:toxicity; D008297:Male; D051379:Mice; D010101:Oxygen Consumption / Q000187:drug effects; D011817:Rabbits; D011832:Radiation Injuries / Q000517:prevention & control; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D012160:Retina / Q000187:drug effects; D014020:Tissue Extracts / Q000627:therapeutic use*
D001565:Benzoates; D007452:Iodates; D011837:Radiation-Protective Agents; D014020:Tissue Extracts; D000183:Actihaemyl; D019817:Benzoic Acid